Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ablynx Extends Ion Channel Research Collaboration With Merck & Co., Inc.

Wednesday, October 12, 2016

Ablynx announced a second extension of its research collaboration with a subsidiary of Merck Co Inc Kenilworth NJ USA known as MSD outside the United States and Canada to develop and commercialise Nanobody candidates directed towards an undisclosed...

France opens its first supervised injection center for drug users

Wednesday, October 12, 2016

France inaugurated its first supervised injection facility for drug users on Tuesday setting aside years of acrimonious debate over the merits of a strategy that has slowly gained traction since the Swiss embraced it three decades ago Frances Social...

Innate Pharma announced data for two Phase I studies for lirilumab and nivolumab

Monday, October 10, 2016

Innate Pharma SA Announced on Sunday safety data for two Phase I studies conducted by BristolMyers Squibb Combination of lirilumab and nivolumab in Phase I study of advanced solid tumors showed no added toxicity over nivolumab monotherapy Data suppo...

Exelixis and Pfizer drugs face off in kidney cancer

Monday, October 10, 2016

Exelixis drug Cabometyx beat Pfizers Sutent in a clinical study in metastatic kidney cancer suggesting it has the potential to become a firstline treatment researchers said on Monday The drug is currently approved only in patients who have already r...

Mylan to pay $465 million over EpiPen Medicaid rebate dispute

Saturday, October 08, 2016

Mylan NV MYLO on Friday said it will pay million to settle questions of whether it underpaid US government healthcare programs by misclassifying its EpiPen emergency allergy treatment which has come under intense scrutiny after a series of drastic p...

Moleculin Biotech announces plan for clinical trial drug production

Saturday, October 08, 2016

Moleculin Biotech Inc Has secured an agreement with Dermin Sp Zo O Dermin to utilize Dermins supply of Annamycin for its upcoming clinical trial Agreement reached allows company to utilize Annamycin in upcoming clinical trials rather than having to...

Astellas Filed Lawsuit against Patent Infringement of Myrbetriq® in the United States

Friday, October 07, 2016

Astellas Pharma Inc and its subsidiaries jointly filed a lawsuit against Actavis Elizabeth LLC and its affiliates Actavis who filed an abbreviated new drug application ANDA for a generic version of Astellas mirabegron generic name product sold under...

RaQualia Pharma gets substance patent for ghrelin receptor agonist(serine derivative) in Japan

Friday, October 07, 2016

RaQualia Pharma Inc Says it received substance patent for ghrelin receptor agonistserine derivative in Japan Says the substance is used for improvement of anorexia and suppression of body weight reduction Source reuterscom

Thousands of European melanoma patients lack access to new drugs

Friday, October 07, 2016

More than a quarter of European patients with advanced melanoma lack access to new treatments that could extend their lives according to findings presented at a major cancer conference on Friday In the last five years novel medicines have revolution...

Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products

Friday, October 07, 2016

Lupin Pharmaceutical Inc the US subsidiary of pharma major Lupin Limited collectively Lupin and MonoSol Rx a specialty pharmaceutical company have entered into a strategic licensing agreement wherein Lupin would develop multiple pediatric products ut...